Pollak P - Search Results

1

The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.

Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, Comar D. Broussolle E, et al. Among authors: pollak p. J Neurol Sci. 1999 Jul 1;166(2):141-51. doi: 10.1016/s0022-510x(99)00127-6. J Neurol Sci. 1999. PMID: 10475108

2

Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.

Dentresangle C, Veyre L, Le Bars D, Pierre C, Lavenne F, Pollak P, Guerin J, Froment JC, Brousolle E. Dentresangle C, et al. Among authors: pollak p. Mov Disord. 1999 Nov;14(6):1025-30. doi: 10.1002/1531-8257(199911)14:6<1025::aid-mds1020>3.0.co;2-p. Mov Disord. 1999. PMID: 10584682 No abstract available.

3

[18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations.

Broussolle E, Lücking CB, Ginovart N, Pollak P, Remy P, Dürr A. Broussolle E, et al. Among authors: pollak p. Neurology. 2000 Sep 26;55(6):877-9. doi: 10.1212/wnl.55.6.877. Neurology. 2000. PMID: 10994015

4

Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.

Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P, Koudsie A, Le Bars D, Benabid AL, Broussolle E. Thobois S, et al. Among authors: pollak p. J Neurol. 2003 Oct;250(10):1219-23. doi: 10.1007/s00415-003-0188-z. J Neurol. 2003. PMID: 14586606 Clinical Trial.

5

Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.

Broussolle E, Cinotti L, Pollak P, Landais P, Le Bars D, Galy G, Lavenne F, Khalfallah Y, Chazot G, Mauguière F. Broussolle E, et al. Among authors: pollak p. Mov Disord. 1993 Oct;8(4):459-62. doi: 10.1002/mds.870080407. Mov Disord. 1993. PMID: 8232355

6

Overactivation of primary motor cortex is asymmetrical in hemiparkinsonian patients.

Thobois S, Dominey P, Decety J, Pollak P, Gregoire MC, Broussolle E. Thobois S, et al. Among authors: pollak p. Neuroreport. 2000 Mar 20;11(4):785-9. doi: 10.1097/00001756-200003200-00026. Neuroreport. 2000. PMID: 10757520

7

[Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].

Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P. Thobois S, et al. Among authors: pollak p. Rev Neurol (Paris). 2010 Oct;166(10):816-21. doi: 10.1016/j.neurol.2010.07.006. Epub 2010 Aug 23. Rev Neurol (Paris). 2010. PMID: 20739041 Review. French.

8

Bilateral subthalamic nucleus stimulation for severe Parkinson's disease.

Limousin P, Pollak P, Benazzouz A, Hoffmann D, Broussolle E, Perret JE, Benabid AL. Limousin P, et al. Among authors: pollak p. Mov Disord. 1995 Sep;10(5):672-4. doi: 10.1002/mds.870100523. Mov Disord. 1995. PMID: 8552123

9

Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography.

Deiber MP, Pollak P, Passingham R, Landais P, Gervason C, Cinotti L, Friston K, Frackowiak R, Mauguière F, Benabid AL. Deiber MP, et al. Among authors: pollak p. Brain. 1993 Feb;116 ( Pt 1):267-79. doi: 10.1093/brain/116.1.267. Brain. 1993. PMID: 8453462

10

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.

Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL. Limousin P, et al. Among authors: pollak p. Lancet. 1995 Jan 14;345(8942):91-5. doi: 10.1016/s0140-6736(95)90062-4. Lancet. 1995. PMID: 7815888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters